BenzingaOctober 9, 2026 at 9:19 AM NY18 Days Ago
RBC Capital Maintains Underperform on Amrize, Lowers Price Target to $32
RBC Capital analyst Anthony Codling maintains Amrize (NYSE:AMRZ) with a Underperform and lowers the price target from $48 to $32.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
